Want to see AU:RAC full AI Analyst Report?
Total Valuation
Race Oncology Ltd. has a market cap or net worth of AU$396.06M. The enterprise value is AU$367.74.
Market CapAU$396.06M
Enterprise ValueAU$367.74
Share Statistics
Race Oncology Ltd. has 196,068,940 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding196,068,940
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Race Oncology Ltd.’s return on equity (ROE) is -0.30 and return on invested capital (ROIC) is -27.25%.
Return on Equity (ROE)-0.30
Return on Assets (ROA)-0.29
Return on Invested Capital (ROIC)-27.25%
Return on Capital Employed (ROCE)-0.34
Revenue Per Employee0.00
Profits Per Employee-2.22M
Employee Count5
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Race Oncology Ltd. is ―. Race Oncology Ltd.’s PEG ratio is -0.29.
PE Ratio―
PS Ratio0.00
PB Ratio10.91
Price to Fair Value10.91
Price to FCF-48.21
Price to Operating Cash Flow-45.90
PEG Ratio-0.29
Income Statement
In the last 12 months, Race Oncology Ltd. had revenue of 0.00 and earned -11.09M in profits. Earnings per share was -0.06.
Revenue0.00
Gross Profit-281.31K
Operating Income-12.43M
Pretax Income-13.87M
Net Income-11.09M
EBITDA-12.15M
Earnings Per Share (EPS)-0.06
Cash Flow
In the last 12 months, operating cash flow was -8.25M and capital expenditures -3.67K, giving a free cash flow of -8.25M billion.
Operating Cash Flow-8.25M
Free Cash Flow-8.25M
Free Cash Flow per Share-0.04
Dividends & Yields
Race Oncology Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.21
52-Week Price Change-32.14%
50-Day Moving Average2.08
200-Day Moving Average2.43
Relative Strength Index (RSI)42.46
Average Volume (3m)82.48K
Important Dates
Race Oncology Ltd. upcoming earnings date is Mar 3, 2027, TBA (Confirmed).
Last Earnings DateAug 25, 2026
Next Earnings DateMar 3, 2027
Ex-Dividend Date―
Financial Position
Race Oncology Ltd. as a current ratio of 21.43, with Debt / Equity ratio of 0.00%
Current Ratio21.43
Quick Ratio21.43
Debt to Market Cap0.00
Net Debt to EBITDA2.82
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Race Oncology Ltd. has paid -2.78M in taxes.
Income Tax-2.78M
Effective Tax Rate0.20
Enterprise Valuation
Race Oncology Ltd. EV to EBITDA ratio is -29.91, with an EV/FCF ratio of -44.05.
EV to Sales0.00
EV to EBITDA-29.91
EV to Free Cash Flow-44.05
EV to Operating Cash Flow-44.07
Balance Sheet
Race Oncology Ltd. has AU$34.29M in cash and marketable securities with AU$0.00 in debt, giving a net cash position of AU$34.29M billion.
Cash & Marketable SecuritiesAU$34.29M
Total DebtAU$0.00
Net CashAU$34.29M
Net Cash Per ShareAU$0.17
Tangible Book Value Per ShareAU$0.19
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Race Oncology Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast-125.09%